Clinical Trials Logo

Clinical Trial Summary

Children and adolescents experiencing gender dysphoria feel increased distress with the onset of puberty. Gender clinics treat these young adolescents by "blocking" puberty using gonadotropin-releasing hormone (GnRH) agonist medications. This has the possibility of impacting bone development as sex steroids are important to bone mass development. In this multi-site study, the investigators will examine bone marrow composition (by MRI) in 40 transgender youth and bone density and body composition before/after pubertal blockade compared to healthy participants.


Clinical Trial Description

The investigators propose to identify the effects of pubertal blockade on bone density and size in pediatric transgender individuals. Information is limited regarding bone health and metabolism for this group, and especially for children who are transgender. Further, the team's expertise in magnetic resonance imaging (MRI), magnetic resonance spectroscopy (MRS), dual-energy x-ray absorptiometry (DXA), and peripheral quantitative computed tomography (pQCT), examining the natal female skeleton in previous NIH funded studies, and extensive clinical expertise, provide an ideal foundation to apply this protocol to examine transgender female and transgender male skeleton. Findings from this study will allow us to identify potential preventative strategies to counter the long-term effects of puberty blockade such as osteoporosis and raise awareness of this medical consequence to medical care providers of transgender patients. The proposed project seeks to answer the clinically relevant question of how bone marrow composition relates to body composition, and its relation to both bone density and skeletal strength, in transgender patients who are undergoing puberty blockade, the first phase of therapy preceding gender-affirming hormone therapy. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04203381
Study type Interventional
Source Boston Children's Hospital
Contact Amy M DiVasta, MD
Phone 617-355-7181
Email amy.divasta@childrens.harvard.edu
Status Recruiting
Phase N/A
Start date September 15, 2020
Completion date March 31, 2025

See also
  Status Clinical Trial Phase
Recruiting NCT05008276 - Puberty, Diabetes, and the Kidneys, When Eustress Becomes Distress (PANTHER Study)
Enrolling by invitation NCT05463120 - Minipuberty of Infancy and the Timing of Pubertal Development in Adolescence: a Follow-up of the Infant Feeding and Early Development (IFED) Cohort
Recruiting NCT04723862 - Does Spironolactone Normalize Sleep-wake Luteinizing Hormone Pulse Frequency in Pubertal Girls With Hyperandrogenism? Early Phase 1
Suspended NCT02611128 - Urinary DENND1A.V2 as a Predictor of Pubertal Hyperandrogenemia
Completed NCT01517139 - Diet and Nutrition Pilot Study for Chinese Adolescents and Their Mothers
Recruiting NCT00929006 - Acute Progesterone Suppression of Wake vs. Sleep Luteinizing Hormone Pulse Frequency in Pubertal Girls With and Without Hyperandrogenism Early Phase 1
Recruiting NCT03068910 - Hyperandrogenemia and Altered Day-night LH Pulse Patterns Early Phase 1
Completed NCT01411527 - The COPENHAGEN Puberty Study
Recruiting NCT02155933 - Assessment of Day-night Secretion of Progesterone and LH Across Puberty
Recruiting NCT04424576 - Ovarian Morphology in Girls
Recruiting NCT04884620 - The 3rd COPENHAGEN Puberty Study
Not yet recruiting NCT06237387 - Association of Acne Vulgaris With Oral Hygiene and Gingivitis
Recruiting NCT02583646 - Investigating the Impact of Obesity on Pubertal Development in Girls